Companies: 10,795·Total market cap: $144.5T
Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc.

NVOSOTCHealthcare● Active
$0.01
$-0.01(-55.00%)
Market Cap$177572
P/E Ratio
52W High$0.06
52W Low$0.0001
Overview

Novo Integrated Sciences, Inc. (NVOS) Revenue

Annual & quarterly revenue history · segment & region breakdown

NVOS · revenue · updated Jun 9, 2026

Core revenue metrics

Novo Integrated Sciences, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.01B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
0.01×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$116K
115 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Novo Integrated Sciences, Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
NVOS revenue by year · NVOS revenue history · NVOS annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Novo Integrated Sciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Novo Integrated Sciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Novo Integrated Sciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

NVOS revenue · 4 questions

NVOS's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 0.00% year-over-year from — in FY.

NVOS revenueNVOS annual revenuewhat is NVOS revenueNVOS TTM revenue

Source: FMP · Novo Integrated Sciences, Inc. SEC filings · GAAP · Novo Integrated Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026